dxpx general logo white text

DxPx Europe '26 Exhibitor Booths

Showcase your innovation to the DxPx audience & network with investors/strategics at your own booth. 

Package price: $3,500

DxPx EU '26 Booth Benefits

A Meeting hub at DxPx Europe '26

Your booth is a personal hub to meet with investors and partners.

Enhance visibility among investors

Showcase your company’s USPs and investment opportunities and feature prominently on the floor of DxPx. 

Supplement One-on-One Partnering

Missed connecting with one of your target partners in our digital partnering app? Use your booth as an additional meeting point in between the pre-scheduled one-on-ones. 

Maximize your time at DxPx

Our team handles all booth setup and teardown so that you can fully focus making new connections and making the most of DxPx Europe ’25.

Booths = Maximum Value at DxPx

Two registrations ($2,000 value) are included with each booth purchase. 

Limited Space - Apply Now!

We only grant booth to sponsors and the most innovative startups and growth companies. Spaces are therefore limited to insure that every exhibitor gains the desired exposure.

DxPx Europe '25 Exhibitors::

Aescuvest is a leading, healthcare dedicated FinTech company, with a special focus on financing digital healthcare solutions. Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups – according to their personal investment focus.

For more information, visit: aescuvest.vc

Kanso Diagnostics strives for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Its novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Its proprietary technology offers PCR-grade accuracy with rapid home testing convenience, enabling an end-to-end solution for the diagnosis of bacterial and viral infections anywhere and anytime.

For more information, visit: biomensio.com

Elyte has developed an innovative point-of-care testing (POCT) device, designed specifically for individuals at risk of potassium imbalances due to cardiac or renal conditions. Its cutting-edge technology enables patients to accurately measure and monitor their potassium levels in the comfort of their own homes, a significant advancement from traditional methods that rely on scheduled clinical visits and specialized laboratory equipment.

For more information, visit: elytediagnostics.com

ExpressTec is a simple and elegant solution to the need for recombinant proteins in medicine and biotechnology. Instead of a stainless-steel bioreactor, our production process harnesses the humble rice plant’s natural ability to use sunlight as an energy source and soil, water, and air as raw materials. Desired proteins are manufactured as the plant grows, and naturally become concentrated within the rice-seed endosperm for easy harvest and purification.

For more information, visit: expresstec.bio

Ginolis specializes in precision robotics, assembly automation, high-precision liquid handling, and quality inspection solutions for the global medical device and diagnostics industries, as well as other robotic applications. The company aims to become a leading global systems supplier in the diagnostics industry, driving the shift toward automated production. Ginolis’ liquid handling and desktop automation solutions are recognized for their high quality, precision, and modularity, and the company collaborates with many of the world’s leading diagnostic firms.

For more information, visit: ginolis.com

Kanso Diagnostics strives for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Its novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Its proprietary technology offers PCR-grade accuracy with rapid home testing convenience, enabling an end-to-end solution for the diagnosis of bacterial and viral infections anywhere and anytime.

For more information, visit: linkedin.com/company/kanso-diagnostics/

Limula provides an innovative solution for the production of the most personalized cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.

For more information, visit: limula.ch

lino Biotech is the world’s only company specialized in focal molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays while eliminating signal disturbances due to temperature changes or non-specific binding.

For more information, visit: lino-biotech.com

Loop Diagnostics (Loopdx) has developed a groundbreaking in vitro cellular immunoassay that detects sepsis within the first hour of bloodstream infection. Its patented method identifies immune activity biomarkers with three times the sensitivity of leading competitors and delivers results ten times faster than traditional pathogen identification.

For more information, visit: loopdx.com

Medimir provides a Clinical Decision Support (CDS) System with a physician app offering case-specific treatment recommendations. The tools guide guideline-conform decisions step by step, storing relevant data in a patient database. Available as a single-user app or hospital version, the CE-certified system digitizes clinical guidelines, improving workflow efficiency and compliance with automated documentation.

For more information, visit: medimir.ai

OMAPiX collaborates with academic and pharmaceutical clients on large-scale spatial biology projects, including tissue atlasing, metascience, and pharma studies. Offering end-to-end services from sample preparation to spatial biology experiments, OMAPiX also provides advanced data analytics to extract novel insights from large datasets. Based in Leuven, Belgium, the company serves a global scientific audience and is dedicated to developing and scaling emerging spatial biology technologies.

For more information, visit: omapix.com

Precision Robotics, a startup originating from Imperial College London, is dedicated to developing precise, agile, and intelligent surgical robots that are dexterous, compact, and versatile. Built on technologies pioneered by a research team at Imperial College, the company aims to become a significant player in this rapidly growing field. Located at the Translation and Innovation Hub (I-Hub) of Imperial West, Precision Robotics benefits from state-of-the-art facilities for engineering development and clinical translation.

For more information, visit: pruk.ltd

SLS Partners specializes in the diagnostics and life science tools sector, focusing on co-founding and building innovative companies, investing in high-potential ventures, and providing advisory services to private equity and venture capital firms. The firm is dedicated to translating advanced research into impactful solutions that address critical needs and shape the future of healthcare.

For more information, visit: sls-partners.net

PubGrade is a leading provider of contextual digital advertising, lead generation, and business intelligence solutions for scholarly publishers, societies, and scientific companies. Its integrated platform simplifies access to all services, empowering partners by unlocking the untapped potential of scientific resources.

For more information, visit: pubgrade.com

TÜV Rheinland has stood for ensuring quality, safety, and efficiency in conjunction with people, the environment, and technology for more than 150 years. As a neutral, independent third party, it tests, accompanies, develops, promotes, and certifies products, plants, processes, and management systems, as well as services, based on legal requirements and other relevant performance benchmarks and standards.

For more information, visit: tuv.com/world/en/

Date & Location:

Reception: Thursday, February 5th, 2026

Partnering Day & 42PLUS1: February 6th, 2026

Leonardo Royal Hotel Munich

Moosacher Straße 90 | 80809 München | Germany

 

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience